Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis

202232 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov, NCT03041025; EudraCT, 2016-003417-95.

Good health and well-being

Published in: Lara D. Veeken

Volume 62, Issue 1, pp. 234-242

Field-Weighted Citation Impact: 4.11